Jinling Pharmaceutical Co Ltd (000919) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.015x

Based on the latest financial reports, Jinling Pharmaceutical Co Ltd (000919) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥74.01 Million ≈ $10.83 Million USD) by net assets (CN¥4.85 Billion ≈ $709.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jinling Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Jinling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Jinling Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Jinling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jinling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Transcat Inc
NASDAQ:TRNS
0.041x
Zhang Xiaoquan Inc.
SHE:301055
N/A
Samsung Electro Mechanics Pref
KO:009155
0.030x
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class D
IS:KRDMD
0.031x
Sichuan Goldstone Orient New Material Equipment Co Ltd
SHE:300434
0.063x
MTY Food Group Inc
TO:MTY
0.048x
Advanced Nano Products Co. Ltd
KQ:121600
0.027x
Arvinas Inc
NASDAQ:ARVN
-0.070x

Annual Cash Flow Conversion Efficiency for Jinling Pharmaceutical Co Ltd (1999–2024)

The table below shows the annual cash flow conversion efficiency of Jinling Pharmaceutical Co Ltd from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see 000919 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥4.85 Billion
≈ $709.50 Million
CN¥154.19 Million
≈ $22.56 Million
0.032x -26.26%
2023-12-31 CN¥3.68 Billion
≈ $539.22 Million
CN¥158.92 Million
≈ $23.26 Million
0.043x -39.97%
2022-12-31 CN¥3.63 Billion
≈ $530.75 Million
CN¥260.59 Million
≈ $38.13 Million
0.072x -13.04%
2021-12-31 CN¥3.53 Billion
≈ $517.22 Million
CN¥292.03 Million
≈ $42.73 Million
0.083x -8.93%
2020-12-31 CN¥3.43 Billion
≈ $502.38 Million
CN¥311.46 Million
≈ $45.58 Million
0.091x -33.30%
2019-12-31 CN¥3.42 Billion
≈ $501.14 Million
CN¥465.85 Million
≈ $68.17 Million
0.136x +1.78%
2018-12-31 CN¥3.25 Billion
≈ $475.00 Million
CN¥433.83 Million
≈ $63.48 Million
0.134x -7.89%
2017-12-31 CN¥3.05 Billion
≈ $446.88 Million
CN¥443.11 Million
≈ $64.84 Million
0.145x +360.72%
2016-12-31 CN¥3.05 Billion
≈ $446.75 Million
CN¥96.15 Million
≈ $14.07 Million
0.031x -56.65%
2015-12-31 CN¥2.92 Billion
≈ $427.95 Million
CN¥212.45 Million
≈ $31.09 Million
0.073x -33.36%
2014-12-31 CN¥2.75 Billion
≈ $402.55 Million
CN¥299.89 Million
≈ $43.88 Million
0.109x +3.48%
2013-12-31 CN¥2.57 Billion
≈ $376.72 Million
CN¥271.21 Million
≈ $39.69 Million
0.105x +11.91%
2012-12-31 CN¥2.47 Billion
≈ $360.82 Million
CN¥232.12 Million
≈ $33.97 Million
0.094x +26.66%
2011-12-31 CN¥2.33 Billion
≈ $340.26 Million
CN¥172.82 Million
≈ $25.29 Million
0.074x -8.07%
2010-12-31 CN¥2.20 Billion
≈ $321.83 Million
CN¥177.81 Million
≈ $26.02 Million
0.081x -11.82%
2009-12-31 CN¥2.05 Billion
≈ $300.70 Million
CN¥188.41 Million
≈ $27.57 Million
0.092x -43.58%
2008-12-31 CN¥1.88 Billion
≈ $274.89 Million
CN¥305.26 Million
≈ $44.67 Million
0.162x +168.31%
2007-12-31 CN¥1.95 Billion
≈ $285.26 Million
CN¥118.06 Million
≈ $17.28 Million
0.061x -25.72%
2006-12-31 CN¥1.70 Billion
≈ $248.57 Million
CN¥138.50 Million
≈ $20.27 Million
0.082x +16.56%
2005-12-31 CN¥1.56 Billion
≈ $228.64 Million
CN¥109.29 Million
≈ $15.99 Million
0.070x -35.69%
2004-12-31 CN¥1.47 Billion
≈ $214.99 Million
CN¥159.81 Million
≈ $23.38 Million
0.109x -7.32%
2003-12-31 CN¥1.38 Billion
≈ $201.81 Million
CN¥161.86 Million
≈ $23.69 Million
0.117x +11.72%
2002-12-31 CN¥1.24 Billion
≈ $181.58 Million
CN¥130.36 Million
≈ $19.08 Million
0.105x +26.04%
2001-12-31 CN¥1.11 Billion
≈ $162.39 Million
CN¥92.49 Million
≈ $13.53 Million
0.083x -61.78%
2000-12-31 CN¥1.06 Billion
≈ $155.22 Million
CN¥231.31 Million
≈ $33.85 Million
0.218x +458.19%
1999-12-31 CN¥1.02 Billion
≈ $148.96 Million
CN¥39.77 Million
≈ $5.82 Million
0.039x --

About Jinling Pharmaceutical Co Ltd

SHE:000919 China Drug Manufacturers - Specialty & Generic
Market Cap
$672.54 Million
CN¥4.60 Billion CNY
Market Cap Rank
#11048 Global
#3281 in China
Share Price
CN¥7.39
Change (1 day)
+0.96%
52-Week Range
CN¥6.55 - CN¥8.91
All Time High
CN¥16.21
About

Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China and internationally. The company offers Mailuoning injection/oral solutions for the treatment of thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and sequelae, multiple arteriosclerosis, phlebitis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, an… Read more